Literature DB >> 27194769

Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity.

Pablo Garcia-Miranda1,2, Jordan T Becker2, Bayleigh E Benner2, Alexander Blume1, Nathan M Sherer3, Samuel E Butcher4.   

Abstract

UNLABELLED: Human immunodeficiency virus (HIV) replication is strongly dependent upon a programmed ribosomal frameshift. Here we investigate the relationships between the thermodynamic stability of the HIV type 1 (HIV-1) RNA frameshift site stem-loop, frameshift efficiency, and infectivity, using pseudotyped HIV-1 and HEK293T cells. The data reveal a strong correlation between frameshift efficiency and local, but not overall, RNA thermodynamic stability. Mutations that modestly increase the local stability of the frameshift site RNA stem-loop structure increase frameshift efficiency 2-fold to 3-fold in cells. Thus, frameshift efficiency is determined by the strength of the thermodynamic barrier encountered by the ribosome. These data agree with previous in vitro measurements, suggesting that there are no virus- or host-specific factors that modulate frameshifting. The data also indicate that there are no sequence-specific requirements for the frameshift site stem-loop. A linear correlation between Gag-polymerase (Gag-Pol) levels in cells and levels in virions supports the idea of a stochastic virion assembly mechanism. We further demonstrate that the surrounding genomic RNA secondary structure influences frameshift efficiency and that a mutation that commonly arises in response to protease inhibitor therapy creates a functional but inefficient secondary slippery site. Finally, HIV-1 mutants with enhanced frameshift efficiencies are significantly less infectious, suggesting that compounds that increase frameshift efficiency by as little as 2-fold may be effective at suppressing HIV-1 replication. IMPORTANCE: HIV, like many retroviruses, utilizes a -1 programmed ribosomal frameshift to generate viral enzymes in the form of a Gag-Pol polyprotein precursor. Thus, frameshifting is essential for viral replication. Here, we utilized a panel of mutant HIV strains to demonstrate that in cells, frameshifting efficiency is correlated with the stability of the local thermodynamic barrier to ribosomal translocation. Increasing the stability of the frameshift site RNA increases the frameshift efficiency 2-fold to 3-fold. Mutant viruses with increased frameshift efficiencies have significantly reduced infectivity. These data suggest that this effect might be exploited in the development of novel antiviral strategies.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27194769      PMCID: PMC4944283          DOI: 10.1128/JVI.00149-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Targeting frameshifting in the human immunodeficiency virus.

Authors:  Léa Brakier-Gingras; Johanie Charbonneau; Samuel E Butcher
Journal:  Expert Opin Ther Targets       Date:  2012-03       Impact factor: 6.902

2.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Molecular biology of human immunodeficiency virus type 1.

Authors:  W K Wang; M Y Chen; C Y Chuang; K T Jeang; L M Huang
Journal:  J Microbiol Immunol Infect       Date:  2000-09       Impact factor: 4.399

5.  Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions.

Authors:  Silas F Johnson; John T Collins; Victoria M D'Souza; Alice Telesnitsky
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

6.  Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA.

Authors:  Ryan J Marcheschi; Kathryn D Mouzakis; Samuel E Butcher
Journal:  ACS Chem Biol       Date:  2009-10-16       Impact factor: 5.100

7.  Guanidinoneomycin B recognition of an HIV-1 RNA helix.

Authors:  David W Staple; Vincenzo Venditti; Neri Niccolai; Lev Elson-Schwab; Yitzhak Tor; Samuel E Butcher
Journal:  Chembiochem       Date:  2008-01-04       Impact factor: 3.164

8.  Structure-function analysis of the ribosomal frameshifting signal of two human immunodeficiency virus type 1 isolates with increased resistance to viral protease inhibitors.

Authors:  Roseanne Girnary; Louise King; Laurence Robinson; Robert Elston; Ian Brierley
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

9.  High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity.

Authors:  Leslie O Ofori; Thomas A Hilimire; Ryan P Bennett; Nathaniel W Brown; Harold C Smith; Benjamin L Miller
Journal:  J Med Chem       Date:  2014-01-15       Impact factor: 7.446

10.  Highly conserved RNA pseudoknots at the Gag-Pol junction of HIV-1 suggest a novel mechanism of -1 ribosomal frameshifting.

Authors:  Xiaolan Huang; Yang Yang; Guan Wang; Qiang Cheng; Zhihua Du
Journal:  RNA       Date:  2014-03-26       Impact factor: 4.942

View more
  18 in total

Review 1.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

2.  Enhancing the ligand efficiency of anti-HIV compounds targeting frameshift-stimulating RNA.

Authors:  Viktoriya S Anokhina; John D McAnany; Jessica H Ciesla; Thomas A Hilimire; Netty Santoso; Hongyu Miao; Benjamin L Miller
Journal:  Bioorg Med Chem       Date:  2019-05-09       Impact factor: 3.641

3.  Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Authors:  Joseph A Kendra; Cynthia de la Fuente; Ashwini Brahms; Caitlin Woodson; Todd M Bell; Bin Chen; Yousuf A Khan; Jonathan L Jacobs; Kylene Kehn-Hall; Jonathan D Dinman
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific.

Authors:  Edward L Evans; Jordan T Becker; Stephanie L Fricke; Kishan Patel; Nathan M Sherer
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

5.  Subcellular Localization of HIV-1 gag-pol mRNAs Regulates Sites of Virion Assembly.

Authors:  Jordan T Becker; Nathan M Sherer
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

6.  Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a cis Preference for Gag-Pol Incorporation into Assembling Virions.

Authors:  Bayleigh E Benner; James W Bruce; Jacob R Kentala; Magdalena Murray; Jordan T Becker; Pablo Garcia-Miranda; Paul Ahlquist; Samuel E Butcher; Nathan M Sherer
Journal:  J Virol       Date:  2021-10-13       Impact factor: 6.549

Review 7.  SHAPE Directed Discovery of New Functions in Large RNAs.

Authors:  Kevin M Weeks
Journal:  Acc Chem Res       Date:  2021-05-07       Impact factor: 22.384

Review 8.  Unconventional viral gene expression mechanisms as therapeutic targets.

Authors:  Jessica Sook Yuin Ho; Zeyu Zhu; Ivan Marazzi
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

9.  Identification of host proteins differentially associated with HIV-1 RNA splice variants.

Authors:  Rachel Knoener; Edward Evans; Jordan T Becker; Mark Scalf; Bayleigh Benner; Nathan M Sherer; Lloyd M Smith
Journal:  Elife       Date:  2021-02-25       Impact factor: 8.140

Review 10.  From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

Authors:  John F Atkins; Kate M O'Connor; Pramod R Bhatt; Gary Loughran
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.